Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to Prostate

被引：2
|
作者：
Reddy, K. [1 ]
Nelson, B. C. [1 ]
McCammon, R. [2 ]
Rusthoven, K. E. [1 ]
Newman, F. [1 ]
Kavanagh, B. [1 ]
Raben, D. [1 ]
机构：
[1] Univ Colorado, Aurora, CO USA
[2] SE Radiat Oncol, Charlotte, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [21] Acute toxicity of hypofractionated IMRT with simultaneous integrated boost in high-risk prostate cancer patients
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    Souhami, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S689 - S689
  • [22] Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer
    Quon, Harvey
    Cheung, Patrick C. F.
    Loblaw, D. Andrew
    Morton, Gerard
    Pang, Geordi
    Szumacher, Ewa
    Danjoux, Cyril
    Choo, Richard
    Kiss, Alex
    Mamedov, Alexandre
    Deabreu, Andrea
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 617 - 623
  • [23] IMAGE-GUIDED INTENSITY MODULATED HYPOFRACTIONATED RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER PATIENTS: TOXICITY AND PRELIMINARY RESULTS
    Valeriani, Maurizio
    Bonome, Paolo
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Bracci, Stefano
    Agolli, Linda
    Enrici, Riccardo Maurizi
    ANTICANCER RESEARCH, 2015, 35 (06) : 3702 - 3702
  • [24] PELVIC IMRT WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH RISK (SCORE NCCN) PROSTATE CANCER
    Magli, A.
    Malisan, M. R.
    Foti, C.
    Moretti, E.
    Marino, M.
    Prisco, A.
    Polsinelli, M.
    Signor, M.
    Fongione, S.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S411 - S411
  • [25] Hypofractionated IMRT With Simultaneous Integrated Boost for High-risk Prostate Cancer Patients: Acute Toxicity Report
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S364 - S364
  • [26] Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
    Wang, Michael
    Pearcey, Robert
    Pervez, Nadeem
    Yee, Don
    Mihai, Alina
    Patel, Samir
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [27] Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
    Yuh, Bertram E.
    Ruel, Nora H.
    Mejia, Rosa
    Wilson, Chelsea M.
    Wilson, Timothy G.
    EUROPEAN UROLOGY, 2012, 61 (05) : 1004 - 1010
  • [28] Comparison of helical tomotherapy with multi-field intensity-modulated radiotherapy treatment plans using simultaneous integrated boost in high-risk prostate cancer
    Basaran, Hamit
    Karaca, Sibel
    Koca, Timur
    Gundogdu, Yasemin Ors
    POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING, 2021, 27 (02): : 143 - 149
  • [29] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [30] Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer
    Loblaw, Andrew
    CANCER JOURNAL, 2020, 26 (01): : 38 - 42
12345